Description
Modafresh 200mg Modafinil Product Information
Product Overview
Modafresh is a branded tablet presentation labelled as containing modafinil, a wakefulness-promoting medicine used in defined medical circumstances. The supplied image shows Modafresh-200 wording on a white carton, magenta lettering, a green line and a printed silver blister. Brand identity, ingredient, strength and legal status are distinct facts. The photograph does not establish UK authorisation.
Modafresh 200mg Product Details
| Product characteristic | Details |
| Product name | Modafresh |
| Brand | Modafresh |
| Active ingredient | Modafinil |
| Labelled strength | 200mg per tablet |
| Form | Tablet |
| Category | Modafinil |
| Carton notation | 10 × 10 Tablets |
| Presentation | White carton and printed silver blister |
| Visible name | Sunrise |
The 10 × 10 notation describes pictured packaging, not necessarily an individual order quantity. Sunrise wording does not verify the legal manufacturer or authorisation holder.
Modafresh 200 mg (Modafinil): Product and UK Context
Modafresh identifies the brand; modafinil is its stated active ingredient. The 200mg figure identifies labelled strength, not a recommended amount. In the UK, modafinil is prescription-only. Authorisation of another medicine containing modafinil does not establish the legal status or pharmaceutical characteristics of this presentation.
What Is Modafinil?
Modafinil is a centrally acting wakefulness-promoting medicine. Its recognised UK-licensed indication is excessive sleepiness associated with narcolepsy in adults, with or without cataplexy. Narcolepsy is a neurological sleep disorder associated with significant daytime sleepiness. Its medical indication should not be confused with unsupported claims about productivity, concentration or academic performance.
How Modafinil Works
Modafinil acts on neurological pathways involved in wakefulness, including dopamine-related signalling. Its precise mechanism is not completely understood. Like other medicines, it can cause adverse reactions and interact with other treatments. Ingredient-level research is not independent evidence of the effects or quality of a particular branded formulation.
Recognised Medical Context of Modafinil
Narcolepsy may involve cataplexy, episodes of sudden muscle weakness sometimes triggered by emotion. Daytime sleepiness can have several causes, so a recognised medicine indication does not establish suitability for everyone experiencing fatigue. Decisions about diagnosis and prescribing involve clinical assessment rather than packaging information.
Medical and Regulatory Context
Prescription-only medicines in the UK are subject to statutory requirements and professional oversight. Legal supply ordinarily requires an appropriate prescription and lawful pharmacy arrangements. Information about a licensed modafinil medicine cannot verify Modafresh-specific marketing authorisation, prescription checks or supply-chain compliance.
Researching Modafresh 200
Product research involves ingredient information, brand-specific documentation and regulatory records. Ingredient sources describe recognised uses and safety; brand documentation can address formulation and pack identity; regulatory records establish relevant permissions. Similar names, strengths or packaging do not prove pharmaceutical equivalence, authenticity or interchangeability.
Ordering Process
The website describes the following administrative sequence, not evidence of lawful supply:
- Customer places an order.
- Email confirmation request is sent.
- WhatsApp confirmation may also be sent where available.
- Customer confirms the order.
- Payment instructions are provided.
- Customer makes payment.
- Payment acknowledgement / thank-you communication is sent.
- Optional WhatsApp acknowledgement may also be sent.
- The 48-hour dispatch target begins when payment is made.
- Tracking information is provided after dispatch.
Payment and Dispatch
The stated arrangement does not collect payment directly at website checkout. An order is confirmed before payment instructions are provided, followed by acknowledgement. The 48-hour target starts after payment and concerns dispatch, not guaranteed delivery. Tracking follows dispatch; carrier and transit times are unspecified. Any fulfilment remains subject to applicable prescription and medicines requirements.
Product Research Checklist
Relevant checks include ingredient identity, labelled strength, dosage form, pack information, independent product documentation, regulatory authorisation and the status of the supplier. Shared ingredients and similar visual designs are not evidence of bioequivalence or assured quality.
Product Quality and Identification
The original picture shows a white carton with magenta Modafresh-200 lettering, a green graphic line and a silver blister carrying magenta printing. Sunrise wording is visible. A translucent MODALERT watermark overlays the photograph and is not packaging branding. The image cannot verify authenticity, manufacturing country, batch, expiry, authorised supply or pharmaceutical quality.
Modafresh Safety Considerations
Modafinil information identifies precautions relating to cardiovascular health, psychiatric history, severe medicine reactions and interactions. The stated tablet strength is not proof of suitability for an individual.
Side Effects and Interactions
Reported effects include headache, nausea, dizziness, nervousness and insomnia or difficulty sleeping. More serious concerns include severe skin reactions, psychiatric effects and cardiovascular complications. Interactions with other medicines may be clinically important. Modafinil can reduce the effectiveness of some hormonal contraceptives. UK safety information associates exposure during pregnancy with increased risk of congenital malformations and states that modafinil should not be used during pregnancy. Effective contraception is relevant during treatment and for two months afterwards.
Who Should Seek Professional Advice?
Clinical assessment is relevant to people with cardiovascular or psychiatric conditions, those taking other medicines, and those concerned about pregnancy, contraception or previous severe reactions. Doctors and pharmacists can address individual circumstances. Product pages and packaging photographs cannot replace appropriate assessment.
Customer Support
The website describes email communication and optional WhatsApp confirmation or acknowledgement. Administrative enquiries may concern order status, payment messages and post-dispatch tracking. Customer support is separate from prescribing, medicine safety assessment and regulatory verification.
Frequently Asked Questions
1. What is Modafresh 200mg?
Modafresh is a branded tablet presentation labelled as containing modafinil. The pictured carton shows a stated 200mg strength and blister packaging. These details support product identification but do not independently verify chemical composition, authenticity, pharmaceutical quality or UK marketing authorisation. Regulatory status and lawful supply require further documentation.
2. What is the active ingredient in Modafresh 200mg?
The label states modafinil as the active ingredient. The upper carton panel reads Modafinil Tablets USP 200 mg, identifying the declared medicine and tablet strength. This is evidence of packaging wording, not independent laboratory confirmation of contents, complete formulation or equivalence to another medicine containing modafinil.
3. What does Modafresh 200mg mean?
The name combines the Modafresh brand with a stated tablet strength of 200mg. That figure describes the labelled amount of active ingredient per tablet rather than a treatment recommendation. The naming convention alone does not confirm an approved formulation, individual suitability or the marketing authorisation of the specific product.
4. What is Modafinil?
Modafinil is a prescription-only wakefulness-promoting medicine in the United Kingdom. Its recognised licensed use concerns excessive sleepiness in adults with narcolepsy. Its activity involves neurological systems regulating wakefulness, although the exact mechanism remains incompletely understood. This medical context does not establish any approved use for general productivity or academic performance.
5. Is Modafinil prescription-only in the UK?
Yes. Modafinil is classified as a prescription-only medicine in the UK, and lawful supply is subject to prescription and medicines requirements. A recognised licence for one modafinil medicine does not automatically extend to every brand. Product-specific authorisation and the legal status of the supplier must be distinguished from general ingredient information.
6. What does Modafresh 200mg mean as the focus keyword on this page?
It is the primary search phrase identifying the branded tablet presentation and its declared strength. Its role is to organise information about visible packaging, active ingredient, recognised medical context and legal status. Its presence in page metadata or headings does not indicate a clinical recommendation, verified quality or regulatory endorsement.
7. Where can I find payment and shipping information?
The Ordering Process and Payment and Dispatch sections explain the stated workflow. Email confirmation precedes payment instructions; optional WhatsApp communication may also occur. Website checkout does not collect payment directly. The 48-hour target begins after payment and relates to dispatch, not delivery. Tracking information follows dispatch, subject to lawful fulfilment.
8. What is the difference between Modafresh 200mg and Modalert 200mg?
Modafresh and Modalert are separate branded names associated with products labelled as containing modafinil. A shared active ingredient and matching stated strength do not establish identical formulation, bioequivalence, interchangeability or the same marketing authorisation. Meaningful comparison requires independently verified information about each specific product and its regulatory position.
Medical Information Notice
This page provides product identification and general ingredient education, not diagnosis, dosage instructions or personalised treatment advice. Modafinil is prescription-only in the UK, and information about licensed medicines does not verify authorisation of this branded presentation.
Reviews
There are no reviews yet.